SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer.

Donghui LiuMenglin LiuWenxin WangXiaoxue LiEnhong ShiChenyao ZhangYinghui WangYan Zhang Liru Wang Xuyao Wang

Published in: Journal of oncology (2023)

SMYDs are differentially expressed in GC and are thus potential prognostic markers. SMYD expression is closely related to immune infiltration, TMB, and MSI, all of which are closely related to the response to targeted immune therapy.

Keyphrases

poor prognosis
human health
cancer therapy
stem cells
risk assessment
drug delivery
binding protein
climate change